Laplace Interventional

Laplace Interventional is a medical device company that develops transcatheter tricuspid valve technologies. Laplace Interventional's devices aim to improve the life expectancy and quality of life for patients worldwide diagnosed with tricuspid regurgitation (TR). Laplace Interventional is developing an artificial valve that should be delivered through minimally invasive surgery, eliminating the need for open-heart surgery and thereby reducing future complications for patients.